The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers.

The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers.

Item
http://www.wikidata.org/entity/Q39041347
Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study.Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.miR-211 regulates the expression of RRM2 in tumoral metastasis and recurrence in colorectal cancer patients with a k-ras gene mutation.Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.Downregulation of miR‑224‑5p in prostate cancer and its relevant molecular mechanism via TCGA, GEO database and in�silico analyses
P2860

The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers.

Item
http://www.wikidata.org/entity/Q39041347
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The prognostic value of ribonu ...... currence for prostate cancers.
@en
The prognostic value of ribonu ...... currence for prostate cancers.
@nl
type
label
The prognostic value of ribonu ...... currence for prostate cancers.
@en
The prognostic value of ribonu ...... currence for prostate cancers.
@nl
prefLabel
The prognostic value of ribonu ...... currence for prostate cancers.
@en
The prognostic value of ribonu ...... currence for prostate cancers.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
The prognostic value of ribonu ...... ecurrence for prostate cancers
@en
P2093
P304
P31
P356
10.1016/J.UROLONC.2013.08.002
P433
P478
P50
P577
P5875
P698